Global Veterinary Genetic Engineering Vaccines Market Growth 2026-2032
The global Veterinary Genetic Engineering Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 578%.
LP Information, Inc. (LPI) ' newest research report, the ?Veterinary Genetic Engineering Vaccines Industry Forecast? looks at past sales and reviews total world Veterinary Genetic Engineering Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Genetic Engineering Vaccines sales for 2026 through 2032. With Veterinary Genetic Engineering Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Genetic Engineering Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Genetic Engineering Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Genetic Engineering Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Genetic Engineering Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Genetic Engineering Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Genetic Engineering Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Genetic Engineering Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 578%.
LP Information, Inc. (LPI) ' newest research report, the ?Veterinary Genetic Engineering Vaccines Industry Forecast? looks at past sales and reviews total world Veterinary Genetic Engineering Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Genetic Engineering Vaccines sales for 2026 through 2032. With Veterinary Genetic Engineering Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Genetic Engineering Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Genetic Engineering Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Genetic Engineering Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Genetic Engineering Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Genetic Engineering Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Genetic Engineering Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Genetic Engineering Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Genetic Recombinant Vaccine
- Recombinant Subunit Vaccines
- Genetic Vaccine
- Poultry
- Livestock
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer Ingelheim
- Indian Immunologicals
- China Animal Husbandry Industry Co.,Ltd.
- Yebio Bioengineering Co., Ltd Of Qingdao
- Jinyu Bio-technology Co.,ltd.
- HVRI
- Ringpu Biology
- Kyoto Biken Laboratories
- FATRO
- Ceva Sant? Animale
- Pulike Biological Engineering,Inc.
- Wuhan Hvsen Biotechnology CO.,LTD
- Jinhe Biotechnology Co., Ltd.
- Shanghai Shen Lian Biomedical Corporation
- Qingdao Vland Biotech INC.
- What is the 10-year outlook for the global Veterinary Genetic Engineering Vaccines market?
- What factors are driving Veterinary Genetic Engineering Vaccines market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Veterinary Genetic Engineering Vaccines market opportunities vary by end market size?
- How does Veterinary Genetic Engineering Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Veterinary Genetic Engineering Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.2.4 Veterinary Genetic Engineering Vaccines Sales by Type
2.2.4.1 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
2.2.4.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2021-2026)
2.3 Veterinary Genetic Engineering Vaccines Segment by Application
2.3.1 Poultry
2.3.2 Livestock
2.3.3 Other
2.3.4 Veterinary Genetic Engineering Vaccines Sales by Application
2.3.4.1 Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2021-2026)
2.3.4.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Genetic Engineering Vaccines Breakdown Data by Company
3.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Company (2021-2026)
3.2.2 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Genetic Engineering Vaccines Product Location Distribution
3.4.2 Players Veterinary Genetic Engineering Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Genetic Engineering Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Veterinary Genetic Engineering Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Genetic Engineering Vaccines Sales Growth
4.4 APAC Veterinary Genetic Engineering Vaccines Sales Growth
4.5 Europe Veterinary Genetic Engineering Vaccines Sales Growth
4.6 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Growth
5 AMERICAS
5.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country
5.1.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026)
5.1.2 Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026)
5.2 Americas Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
5.3 Americas Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region
6.1.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region (2021-2026)
6.1.2 APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2021-2026)
6.2 APAC Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
6.3 APAC Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Genetic Engineering Vaccines by Country
7.1.1 Europe Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026)
7.1.2 Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026)
7.2 Europe Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
7.3 Europe Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Genetic Engineering Vaccines by Country
8.1.1 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines
10.3 Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
10.4 Industry Chain Structure of Veterinary Genetic Engineering Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Genetic Engineering Vaccines Distributors
11.3 Veterinary Genetic Engineering Vaccines Customer
12 WORLD FORECAST REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
12.1 Global Veterinary Genetic Engineering Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary Genetic Engineering Vaccines Forecast by Region (2027-2032)
12.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Veterinary Genetic Engineering Vaccines Forecast by Type (2027-2032)
12.7 Global Veterinary Genetic Engineering Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.1.3 Merck Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.2.3 GSK Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Zoties
13.4.1 Zoties Company Information
13.4.2 Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.4.3 Zoties Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zoties Main Business Overview
13.4.5 Zoties Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.5.3 Elanco Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.7.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
13.8 China Animal Husbandry Industry Co.,Ltd.
13.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.8.2 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.8.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.9 Yebio Bioengineering Co., Ltd Of Qingdao
13.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.10 Jinyu Bio-technology Co.,ltd.
13.10.1 Jinyu Bio-technology Co.,ltd. Company Information
13.10.2 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.10.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.11 HVRI
13.11.1 HVRI Company Information
13.11.2 HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.11.3 HVRI Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 HVRI Main Business Overview
13.11.5 HVRI Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 Kyoto Biken Laboratories
13.13.1 Kyoto Biken Laboratories Company Information
13.13.2 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Kyoto Biken Laboratories Main Business Overview
13.13.5 Kyoto Biken Laboratories Latest Developments
13.14 FATRO
13.14.1 FATRO Company Information
13.14.2 FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.14.3 FATRO Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 FATRO Main Business Overview
13.14.5 FATRO Latest Developments
13.15 Ceva Sant? Animale
13.15.1 Ceva Sant? Animale Company Information
13.15.2 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.15.3 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Ceva Sant? Animale Main Business Overview
13.15.5 Ceva Sant? Animale Latest Developments
13.16 Pulike Biological Engineering,Inc.
13.16.1 Pulike Biological Engineering,Inc. Company Information
13.16.2 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Pulike Biological Engineering,Inc. Main Business Overview
13.16.5 Pulike Biological Engineering,Inc. Latest Developments
13.17 Wuhan Hvsen Biotechnology CO.,LTD
13.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.17.2 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.17.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.18 Jinhe Biotechnology Co., Ltd.
13.18.1 Jinhe Biotechnology Co., Ltd. Company Information
13.18.2 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.18.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.19 Shanghai Shen Lian Biomedical Corporation
13.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.19.2 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.19.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.20 Qingdao Vland Biotech INC.
13.20.1 Qingdao Vland Biotech INC. Company Information
13.20.2 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Qingdao Vland Biotech INC. Main Business Overview
13.20.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Veterinary Genetic Engineering Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.2.4 Veterinary Genetic Engineering Vaccines Sales by Type
2.2.4.1 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
2.2.4.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2021-2026)
2.3 Veterinary Genetic Engineering Vaccines Segment by Application
2.3.1 Poultry
2.3.2 Livestock
2.3.3 Other
2.3.4 Veterinary Genetic Engineering Vaccines Sales by Application
2.3.4.1 Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2021-2026)
2.3.4.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Genetic Engineering Vaccines Breakdown Data by Company
3.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Company (2021-2026)
3.2.2 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Genetic Engineering Vaccines Product Location Distribution
3.4.2 Players Veterinary Genetic Engineering Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Genetic Engineering Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Veterinary Genetic Engineering Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Genetic Engineering Vaccines Sales Growth
4.4 APAC Veterinary Genetic Engineering Vaccines Sales Growth
4.5 Europe Veterinary Genetic Engineering Vaccines Sales Growth
4.6 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Growth
5 AMERICAS
5.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country
5.1.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026)
5.1.2 Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026)
5.2 Americas Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
5.3 Americas Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region
6.1.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region (2021-2026)
6.1.2 APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2021-2026)
6.2 APAC Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
6.3 APAC Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Genetic Engineering Vaccines by Country
7.1.1 Europe Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026)
7.1.2 Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026)
7.2 Europe Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
7.3 Europe Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Genetic Engineering Vaccines by Country
8.1.1 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines
10.3 Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
10.4 Industry Chain Structure of Veterinary Genetic Engineering Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Genetic Engineering Vaccines Distributors
11.3 Veterinary Genetic Engineering Vaccines Customer
12 WORLD FORECAST REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
12.1 Global Veterinary Genetic Engineering Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary Genetic Engineering Vaccines Forecast by Region (2027-2032)
12.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Veterinary Genetic Engineering Vaccines Forecast by Type (2027-2032)
12.7 Global Veterinary Genetic Engineering Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.1.3 Merck Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.2.3 GSK Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Zoties
13.4.1 Zoties Company Information
13.4.2 Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.4.3 Zoties Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zoties Main Business Overview
13.4.5 Zoties Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.5.3 Elanco Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.7.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
13.8 China Animal Husbandry Industry Co.,Ltd.
13.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.8.2 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.8.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.9 Yebio Bioengineering Co., Ltd Of Qingdao
13.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.10 Jinyu Bio-technology Co.,ltd.
13.10.1 Jinyu Bio-technology Co.,ltd. Company Information
13.10.2 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.10.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.11 HVRI
13.11.1 HVRI Company Information
13.11.2 HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.11.3 HVRI Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 HVRI Main Business Overview
13.11.5 HVRI Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 Kyoto Biken Laboratories
13.13.1 Kyoto Biken Laboratories Company Information
13.13.2 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Kyoto Biken Laboratories Main Business Overview
13.13.5 Kyoto Biken Laboratories Latest Developments
13.14 FATRO
13.14.1 FATRO Company Information
13.14.2 FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.14.3 FATRO Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 FATRO Main Business Overview
13.14.5 FATRO Latest Developments
13.15 Ceva Sant? Animale
13.15.1 Ceva Sant? Animale Company Information
13.15.2 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.15.3 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Ceva Sant? Animale Main Business Overview
13.15.5 Ceva Sant? Animale Latest Developments
13.16 Pulike Biological Engineering,Inc.
13.16.1 Pulike Biological Engineering,Inc. Company Information
13.16.2 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Pulike Biological Engineering,Inc. Main Business Overview
13.16.5 Pulike Biological Engineering,Inc. Latest Developments
13.17 Wuhan Hvsen Biotechnology CO.,LTD
13.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.17.2 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.17.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.18 Jinhe Biotechnology Co., Ltd.
13.18.1 Jinhe Biotechnology Co., Ltd. Company Information
13.18.2 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.18.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.19 Shanghai Shen Lian Biomedical Corporation
13.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.19.2 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.19.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.20 Qingdao Vland Biotech INC.
13.20.1 Qingdao Vland Biotech INC. Company Information
13.20.2 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Qingdao Vland Biotech INC. Main Business Overview
13.20.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 7. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Table 8. Global Veterinary Genetic Engineering Vaccines Revenue by Type (2021-2026) & ($ million)
Table 9. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2021-2026)
Table 10. Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Veterinary Genetic Engineering Vaccines Sale by Application (2021-2026) & (K Units)
Table 12. Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2021-2026)
Table 13. Global Veterinary Genetic Engineering Vaccines Revenue by Application (2021-2026) & ($ million)
Table 14. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2021-2026)
Table 15. Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Veterinary Genetic Engineering Vaccines Sales by Company (2021-2026) & (K Units)
Table 17. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2021-2026)
Table 18. Global Veterinary Genetic Engineering Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2021-2026)
Table 20. Global Veterinary Genetic Engineering Vaccines Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution and Sales Area
Table 22. Players Veterinary Genetic Engineering Vaccines Products Offered
Table 23. Veterinary Genetic Engineering Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Veterinary Genetic Engineering Vaccines Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Veterinary Genetic Engineering Vaccines Sales Market Share Geographic Region (2021-2026)
Table 28. Global Veterinary Genetic Engineering Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Veterinary Genetic Engineering Vaccines Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2021-2026)
Table 32. Global Veterinary Genetic Engineering Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026) & (K Units)
Table 35. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2021-2026)
Table 36. Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 38. Americas Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 39. APAC Veterinary Genetic Engineering Vaccines Sales by Region (2021-2026) & (K Units)
Table 40. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2021-2026)
Table 41. APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 43. APAC Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 44. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026) & (K Units)
Table 45. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 47. Europe Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Veterinary Genetic Engineering Vaccines
Table 53. Key Market Challenges & Risks of Veterinary Genetic Engineering Vaccines
Table 54. Key Industry Trends of Veterinary Genetic Engineering Vaccines
Table 55. Veterinary Genetic Engineering Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Veterinary Genetic Engineering Vaccines Distributors List
Table 58. Veterinary Genetic Engineering Vaccines Customer List
Table 59. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Merck Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 75. Merck Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. GSK Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 80. GSK Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Sanofi Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 85. Sanofi Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Zoties Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 90. Zoties Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Zoties Main Business
Table 92. Zoties Latest Developments
Table 93. Elanco Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 95. Elanco Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Elanco Main Business
Table 97. Elanco Latest Developments
Table 98. Boehringer Ingelheim Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 100. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boehringer Ingelheim Main Business
Table 102. Boehringer Ingelheim Latest Developments
Table 103. Indian Immunologicals Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 105. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Indian Immunologicals Main Business
Table 107. Indian Immunologicals Latest Developments
Table 108. China Animal Husbandry Industry Co.,Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 110. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 112. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 113. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 115. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 117. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 118. Jinyu Bio-technology Co.,ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 120. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Jinyu Bio-technology Co.,ltd. Main Business
Table 122. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 123. HVRI Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 125. HVRI Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. HVRI Main Business
Table 127. HVRI Latest Developments
Table 128. Ringpu Biology Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 130. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Ringpu Biology Main Business
Table 132. Ringpu Biology Latest Developments
Table 133. Kyoto Biken Laboratories Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 135. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Kyoto Biken Laboratories Main Business
Table 137. Kyoto Biken Laboratories Latest Developments
Table 138. FATRO Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 140. FATRO Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. FATRO Main Business
Table 142. FATRO Latest Developments
Table 143. Ceva Sant? Animale Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 145. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Ceva Sant? Animale Main Business
Table 147. Ceva Sant? Animale Latest Developments
Table 148. Pulike Biological Engineering,Inc. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 150. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Pulike Biological Engineering,Inc. Main Business
Table 152. Pulike Biological Engineering,Inc. Latest Developments
Table 153. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 155. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 157. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 158. Jinhe Biotechnology Co., Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 160. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Jinhe Biotechnology Co., Ltd. Main Business
Table 162. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 163. Shanghai Shen Lian Biomedical Corporation Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 165. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Shanghai Shen Lian Biomedical Corporation Main Business
Table 167. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 168. Qingdao Vland Biotech INC. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 170. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Qingdao Vland Biotech INC. Main Business
Table 172. Qingdao Vland Biotech INC. Latest Developments
Table 1. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 7. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Table 8. Global Veterinary Genetic Engineering Vaccines Revenue by Type (2021-2026) & ($ million)
Table 9. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2021-2026)
Table 10. Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Veterinary Genetic Engineering Vaccines Sale by Application (2021-2026) & (K Units)
Table 12. Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2021-2026)
Table 13. Global Veterinary Genetic Engineering Vaccines Revenue by Application (2021-2026) & ($ million)
Table 14. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2021-2026)
Table 15. Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Veterinary Genetic Engineering Vaccines Sales by Company (2021-2026) & (K Units)
Table 17. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2021-2026)
Table 18. Global Veterinary Genetic Engineering Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2021-2026)
Table 20. Global Veterinary Genetic Engineering Vaccines Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution and Sales Area
Table 22. Players Veterinary Genetic Engineering Vaccines Products Offered
Table 23. Veterinary Genetic Engineering Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Veterinary Genetic Engineering Vaccines Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Veterinary Genetic Engineering Vaccines Sales Market Share Geographic Region (2021-2026)
Table 28. Global Veterinary Genetic Engineering Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Veterinary Genetic Engineering Vaccines Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2021-2026)
Table 32. Global Veterinary Genetic Engineering Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026) & (K Units)
Table 35. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2021-2026)
Table 36. Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 38. Americas Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 39. APAC Veterinary Genetic Engineering Vaccines Sales by Region (2021-2026) & (K Units)
Table 40. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2021-2026)
Table 41. APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 43. APAC Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 44. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026) & (K Units)
Table 45. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 47. Europe Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Veterinary Genetic Engineering Vaccines
Table 53. Key Market Challenges & Risks of Veterinary Genetic Engineering Vaccines
Table 54. Key Industry Trends of Veterinary Genetic Engineering Vaccines
Table 55. Veterinary Genetic Engineering Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Veterinary Genetic Engineering Vaccines Distributors List
Table 58. Veterinary Genetic Engineering Vaccines Customer List
Table 59. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Merck Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 75. Merck Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. GSK Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 80. GSK Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Sanofi Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 85. Sanofi Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Zoties Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 90. Zoties Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Zoties Main Business
Table 92. Zoties Latest Developments
Table 93. Elanco Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 95. Elanco Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Elanco Main Business
Table 97. Elanco Latest Developments
Table 98. Boehringer Ingelheim Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 100. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boehringer Ingelheim Main Business
Table 102. Boehringer Ingelheim Latest Developments
Table 103. Indian Immunologicals Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 105. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Indian Immunologicals Main Business
Table 107. Indian Immunologicals Latest Developments
Table 108. China Animal Husbandry Industry Co.,Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 110. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 112. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 113. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 115. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 117. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 118. Jinyu Bio-technology Co.,ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 120. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Jinyu Bio-technology Co.,ltd. Main Business
Table 122. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 123. HVRI Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 125. HVRI Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. HVRI Main Business
Table 127. HVRI Latest Developments
Table 128. Ringpu Biology Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 130. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Ringpu Biology Main Business
Table 132. Ringpu Biology Latest Developments
Table 133. Kyoto Biken Laboratories Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 135. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Kyoto Biken Laboratories Main Business
Table 137. Kyoto Biken Laboratories Latest Developments
Table 138. FATRO Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 140. FATRO Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. FATRO Main Business
Table 142. FATRO Latest Developments
Table 143. Ceva Sant? Animale Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 145. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Ceva Sant? Animale Main Business
Table 147. Ceva Sant? Animale Latest Developments
Table 148. Pulike Biological Engineering,Inc. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 150. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Pulike Biological Engineering,Inc. Main Business
Table 152. Pulike Biological Engineering,Inc. Latest Developments
Table 153. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 155. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 157. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 158. Jinhe Biotechnology Co., Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 160. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Jinhe Biotechnology Co., Ltd. Main Business
Table 162. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 163. Shanghai Shen Lian Biomedical Corporation Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 165. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Shanghai Shen Lian Biomedical Corporation Main Business
Table 167. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 168. Qingdao Vland Biotech INC. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 170. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Qingdao Vland Biotech INC. Main Business
Table 172. Qingdao Vland Biotech INC. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Genetic Engineering Vaccines
Figure 2. Veterinary Genetic Engineering Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Genetic Engineering Vaccines Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Veterinary Genetic Engineering Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Veterinary Genetic Engineering Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Genetic Recombinant Vaccine
Figure 12. Product Picture of Recombinant Subunit Vaccines
Figure 13. Product Picture of Genetic Vaccine
Figure 14. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type in 2026
Figure 15. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2021-2026)
Figure 16. Veterinary Genetic Engineering Vaccines Consumed in Poultry
Figure 17. Global Veterinary Genetic Engineering Vaccines Market: Poultry (2021-2026) & (K Units)
Figure 18. Veterinary Genetic Engineering Vaccines Consumed in Livestock
Figure 19. Global Veterinary Genetic Engineering Vaccines Market: Livestock (2021-2026) & (K Units)
Figure 20. Veterinary Genetic Engineering Vaccines Consumed in Other
Figure 21. Global Veterinary Genetic Engineering Vaccines Market: Other (2021-2026) & (K Units)
Figure 22. Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2025)
Figure 23. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application in 2026
Figure 24. Veterinary Genetic Engineering Vaccines Sales by Company in 2026 (K Units)
Figure 25. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company in 2026
Figure 26. Veterinary Genetic Engineering Vaccines Revenue by Company in 2026 ($ millions)
Figure 27. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company in 2026
Figure 28. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 31. Americas Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 32. APAC Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 33. APAC Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 34. Europe Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 35. Europe Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 38. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2026
Figure 39. Americas Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2021-2026)
Figure 40. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 41. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 42. United States Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region in 2026
Figure 47. APAC Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2021-2026)
Figure 48. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 49. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 50. China Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 54. India Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2026
Figure 58. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2021-2026)
Figure 59. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 60. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 61. Germany Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 62. France Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 69. Egypt Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines in 2026
Figure 75. Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
Figure 76. Industry Chain Structure of Veterinary Genetic Engineering Vaccines
Figure 77. Channels of Distribution
Figure 78. Global Veterinary Genetic Engineering Vaccines Sales Market Forecast by Region (2027-2032)
Figure 79. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Veterinary Genetic Engineering Vaccines
Figure 2. Veterinary Genetic Engineering Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Genetic Engineering Vaccines Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Veterinary Genetic Engineering Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Veterinary Genetic Engineering Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Genetic Recombinant Vaccine
Figure 12. Product Picture of Recombinant Subunit Vaccines
Figure 13. Product Picture of Genetic Vaccine
Figure 14. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type in 2026
Figure 15. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2021-2026)
Figure 16. Veterinary Genetic Engineering Vaccines Consumed in Poultry
Figure 17. Global Veterinary Genetic Engineering Vaccines Market: Poultry (2021-2026) & (K Units)
Figure 18. Veterinary Genetic Engineering Vaccines Consumed in Livestock
Figure 19. Global Veterinary Genetic Engineering Vaccines Market: Livestock (2021-2026) & (K Units)
Figure 20. Veterinary Genetic Engineering Vaccines Consumed in Other
Figure 21. Global Veterinary Genetic Engineering Vaccines Market: Other (2021-2026) & (K Units)
Figure 22. Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2025)
Figure 23. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application in 2026
Figure 24. Veterinary Genetic Engineering Vaccines Sales by Company in 2026 (K Units)
Figure 25. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company in 2026
Figure 26. Veterinary Genetic Engineering Vaccines Revenue by Company in 2026 ($ millions)
Figure 27. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company in 2026
Figure 28. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 31. Americas Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 32. APAC Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 33. APAC Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 34. Europe Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 35. Europe Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue 2021-2026 ($ millions)
Figure 38. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2026
Figure 39. Americas Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2021-2026)
Figure 40. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 41. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 42. United States Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region in 2026
Figure 47. APAC Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2021-2026)
Figure 48. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 49. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 50. China Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 54. India Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2026
Figure 58. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2021-2026)
Figure 59. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 60. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 61. Germany Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 62. France Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2021-2026)
Figure 69. Egypt Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Veterinary Genetic Engineering Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines in 2026
Figure 75. Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
Figure 76. Industry Chain Structure of Veterinary Genetic Engineering Vaccines
Figure 77. Channels of Distribution
Figure 78. Global Veterinary Genetic Engineering Vaccines Sales Market Forecast by Region (2027-2032)
Figure 79. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Application (2027-2032)
